PharmaCyte Biotech

Biotechnology - , California, United States

PharmaCyte Biotech Employees
Kenneth Waggoner

Chief Executive Officer, President and General Counsel

Contact Kenneth Waggoner

Kenneth Waggoner

Chief Executive Officer, President and General Counsel of PharmaCyte Biotech, Inc.

Contact Kenneth Waggoner

Sharad Shinde

Electrical Maintenance Engineer

Contact Sharad Shinde

Contact All PharmaCyte Biotech Employees
PharmaCyte Biotech Senior Management
Kenneth Waggoner

Chief Executive Officer, President and General Counsel

Contact Kenneth Waggoner

Kenneth Waggoner

Chief Executive Officer, President and General Counsel of PharmaCyte Biotech, Inc.

Contact Kenneth Waggoner

Contact All PharmaCyte Biotech Employees
PharmaCyte Biotech Details

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box®." This unique and patented technology will be used as a platform upon which treatments for several types of cancer and diabetes are being developed. PharmaCyte's treatment for cancer involves encapsulating genetically modified live cells that convert an inactive chemotherapy drug into its active or "cancer-killing" form. These encapsulated live cells are placed as close to a cancerous tumor as possible. Once implanted in a patient, a chemotherapy drug which needs to be activated in the body (ifosfamide) is then given intravenously at one-third the normal dose. The ifosfamide is carried by the circulatory system to where the encapsulated cells have been placed. When the ifosfamide, which is normally activated in the liver, comes in contact with the encapsulated live cells, activation of the chemotherapy drug takes place at the source of the cancer without any side effects from the chemotherapy. This "targeted chemotherapy" has proven remarkably effective and safe to use in past clinical trials.In addition to developing a novel treatment for cancer, PharmaCyte is developing a treatment for Type 1 diabetes and Type 2 insulin-dependent diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box® technology.Please follow our social community guidelines when posting and commenting on this page: https://goo.gl/hr8rWZ

PharmaCyte Biotech logo, PharmaCyte Biotech contact details
Website: pharmacyte.com
Employees: 1 - 10
HQ: ["9175952850","9175952850"]
Location: , California, United States
Revenue:
PharmaCyte Biotech Technologies
Email Providers

Outlook

Social Sharing

ShareThis

Tag Management

Google Tag Manager

Other

Google Maps

CSS and JavaScript Libraries

Bootstrap Framework

View All Technologies Used At PharmaCyte Biotech

Contacting PharmaCyte Biotech: Connect with Executives and Employees

Get in Touch with PharmaCyte Biotech Executives and Employees

Connecting with PharmaCyte Biotech's Executives and Workforce

Accessing Contact Information for PharmaCyte Biotech Executives

Connecting with PharmaCyte Biotech: Reach Out to Their Team

Discover How to Contact PharmaCyte Biotech Executives and Staff

Looking to connect with PharmaCyte Biotech executives or employees?

Seeking to Get in Touch with PharmaCyte Biotech Executives or Staff?

Want to Reach Out to PharmaCyte Biotech Executives or Team Members?

In Search of Contact Details for PharmaCyte Biotech Professionals?

Connecting with PharmaCyte Biotech: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z